| Name | Title | Contact Details |
|---|
Christian Health Care Center (CHCC) has been fostering health, healing and wellness in northern New Jersey for more than 100 years. Since its inception, CHCC has grown to offer the most complete continuum of senior living, elder-care, short-term rehabilitation, and mental-health services available on any campus in the area, and serves as a vital source of services and information for clients, residents, patients, consumers, and their sponsors. Our commitment to caring begins with recognizing the intrinsic value of all individuals and helping each person reach his or her highest potential for health, healing, and wellness. In so doing, we seek not only to meet each person`s physical needs, but also to nurture emotional and spiritual well-being. Situated on 78 acres overlooking the Ramapo Mountains, CHCC is a non-profit organization that serves all people, regardless of race, sex, or religion. CHCC has expanded to meet the changing needs of the community and continues to offer care in a compassionate and loving environment consistent with the Christian values upon which we were founded. Senior Life Services include: Independent living (Wyckoff and Wayne), Supportive senior living, Adult day services (Wyckoff and Wayne), Assisted living Memory support, Skilled nursing, Behavior management. Short-term Rehabilitation: Post-acute care including rehabilitation therapy and skilled nursing. Mental-Health Services include: Inpatient psychiatric hospital, Short-term partial-hospitalization program, Outpatient counseling for people of all ages. The Vista: An independent-living community for active adults age 62 and over.
Explore the possibilities of Widex hearing solutions and hearing aids for your lifestyle. Find your next hearing aids and get a risk-free trial!
Haemoscope Corporation is a Niles, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
GGB Industries Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.